Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.

Data from two late-stage studies show that LLY's once-weekly insulin injections achieved results that are similar to daily insulin shots.

BAYRY's late-stage FINEARTS-HF study on finerenone show statistically significant improvement in cardiovascular outcomes in adults with common form of...

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer,...

FORMER journalist and Independent Senator Sunity Maharaj says constitutional reform is the beginning of a means to begin to anchor a culture of...

European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline...

The New Patriotic Party’s running mate Dr Matthew Opoku Prempeh has pointed out what he calls the failures of the opposition National Democratic...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it...

By Niranjan Chandrashekhar Oak China is expanding and modernising its nuclear arsenal at an unprecedented speed. China’s development of newer...